Affiliation:
1. 1University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, 140413, India
2. 2Saraswati institute of pharmacy, Mohali, Punjab, 140413, India
Abstract
In the human body, the largest gland is the liver and does a lot of essential work of the body. Liver damage is the cause of mortality and increasing day by day. Liver disease is caused by multiple factors, such as an autoimmune condition, toxic chemical exposure, viral infection, and dietary factors. Drug-induced liver injury (DILI) is a critical issue in drug development because DILI causes failures in clinical trials and the withdrawal of approved drugs from the market and leading to pathological changes result, including increase in SGOT, SGPT and bilirubin as well as the free radical generation. In this review, contains the animal model of hepatotoxicity with a different cause, their action mech., and procedure with dose. These models include the toxicity caused by chemical, drug, radiation, metal, diet, and high-fat this will lead to pathological changes resulting in hepatotoxicity.
Publisher
Oriental Scientific Publishing Company
Reference90 articles.
1. Bigoniya P, Singh CS, Shukla A. A comprehensive review of different liver toxicants used in experimental pharmacology. Int J Pharm Sci Drug Res. 2009;1:124–35
2. Singh A, Bhat KP,Om P. Clinical biochemistry of hepatotoxicity. J ClinToxicol. 2011, S4:001.
3. Devarbhavi, H., Dierkhising, R., Kremers, W.K. Antituberculosis therapy drug-induced liver injury and acute liver failure.Hepatology 52, 2010, 798–799.
4. Devarbhavi, H., Karanth, D., Prasanna, K.S., Adarsh, C.K., Patil, M., 2011. Drug-induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents. Hepatology 54,2011,1344–1350
5. Recknagel RO. Carbon tetrachloride hepatotoxicity. Pharmacol Rev. 1967,19,145–208.